It is important to note that HP-positive carriers of at least one GSTO1*A variant allele presented an up to three times higher risk of developing gastric atrophy and precancerous gastric lesions (gastric atrophy and/or intestinal metaplasia), compared with the GSTO1*C reference allele. The gene discussed is GSTO1; the disease is chronic atrophic gastritis.